SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $17,573,000 | +163.7% | 89,800 | +129.0% | 0.04% | +87.0% |
| Q2 2020 | $6,664,000 | +32.8% | 39,219 | -9.9% | 0.02% | -23.3% |
| Q1 2020 | $5,019,000 | -32.7% | 43,506 | -50.2% | 0.03% | -36.2% |
| Q3 2019 | $7,457,000 | -17.0% | 87,320 | -32.7% | 0.05% | -21.7% |
| Q2 2019 | $8,986,000 | +18.6% | 129,835 | +25.5% | 0.06% | +36.4% |
| Q1 2019 | $7,577,000 | -3.3% | 103,451 | -25.2% | 0.04% | -12.0% |
| Q4 2018 | $7,839,000 | +281.6% | 138,355 | +419.5% | 0.05% | +525.0% |
| Q3 2018 | $2,054,000 | – | 26,634 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |